US Plans Ebola Treatment Facility in Kenya Raising Health Security and Fiscal Questions
Consumers Spend More in April Despite Elevated Gas Prices Latest Data Shows
Allianz Travel Insurance Review Coverage Options and Market Considerations
Chime Reaches Milestone with First GAAP Profitable Quarter in Q1 2026 Revenue Hits 647 Million
Eli Lilly Positioned as Potential SafeHaven Stock for LongTerm Investors in 2026
Ethereums Path Beyond 4000 Market Factors and Sentiment
ASR Q1 2026 Earnings EPS Misses Estimates Shares Dip 225
VIOT Q4 2022 Earnings Losses Deepen Amid Challenging IoT Market
CLX Q1 2026 Earnings EPS Surprise Lifts Results Despite Flat Revenue
Valens Semiconductor VLN Q1 2026 Earnings EPS Beat Drives 5 Stock Surge Amid Revenue Data Gaps
Mercury General Corporation Q1 2026 Earnings Strong Earnings Beat Driven by Underwriting Discipline
CRVS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline
POET Technologies POET Slips 155 Key Support and Resistance Levels in Focus
Churchill Downs CHDN Surges Over 29 Examining the Momentum and Key Levels
Gamehaus Holdings GMHS Slips 5 as Stock Approaches Key Support at 092
TJX Companies Edges Higher Amid Modest Gains Key Levels in Focus
Infosys INFY Edges Higher as Support Holds Key Levels to Watch
Trump Administrations PFAS Regulation Reversal Sparks Industry and Health Debate
Core Natural Resources CNR Q1 2026 Earnings EPS Beats Estimates by 136 Amid Quiet Market Response
Silexion Therapeutics SLXN Slips 3 as Stock Approaches Key Support at 040
Indian Stock Market Faces Profit Booking as Nifty Sensex Snap Rally
SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms
Wingstop Shares Slide 12 After Earnings Miss Estimates
Pokmon Card Market Surges Nostalgia Speculation and Celebrity Influence Drive MillionDollar Sales
Caribbean Beachfront Development Local Access Rights vs Foreign Real Estate Investment
Private Payrolls Rise 109000 in April Exceeding Forecasts ADP Report
Eli Lillys NextGeneration Obesity Drug Retatrutide Shows Positive Results in Pivotal Trial